Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $5.69 billion. The enterprise value is $7.62 billion.
| Market Cap | 5.69B |
| Enterprise Value | 7.62B |
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | Mar 17, 2025 |
Share Statistics
Bruker has 151.53 million shares outstanding. The number of shares has increased by 2.88% in one year.
| Current Share Class | 151.53M |
| Shares Outstanding | 151.53M |
| Shares Change (YoY) | +2.88% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 31.97% |
| Owned by Institutions (%) | 81.52% |
| Float | 102.99M |
Valuation Ratios
The trailing PE ratio is 71.48 and the forward PE ratio is 14.71. Bruker's PEG ratio is 3.11.
| PE Ratio | 71.48 |
| Forward PE | 14.71 |
| PS Ratio | 1.64 |
| Forward PS | 1.58 |
| PB Ratio | 3.13 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 32.56 |
| P/OCF Ratio | 19.31 |
| PEG Ratio | 3.11 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.71, with an EV/FCF ratio of 43.67.
| EV / Earnings | 95.79 |
| EV / Sales | 2.21 |
| EV / EBITDA | 12.71 |
| EV / EBIT | 19.05 |
| EV / FCF | 43.67 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 1.15.
| Current Ratio | 1.57 |
| Quick Ratio | 0.67 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | 3.56 |
| Debt / FCF | 12.22 |
| Interest Coverage | 7.15 |
Financial Efficiency
Return on equity (ROE) is 4.76% and return on invested capital (ROIC) is 7.23%.
| Return on Equity (ROE) | 4.76% |
| Return on Assets (ROA) | 4.79% |
| Return on Invested Capital (ROIC) | 7.23% |
| Return on Capital Employed (ROCE) | 8.72% |
| Revenue Per Employee | $302,396 |
| Profits Per Employee | $6,985 |
| Employee Count | 11,396 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.59 |
Taxes
In the past 12 months, Bruker has paid $80.30 million in taxes.
| Income Tax | 80.30M |
| Effective Tax Rate | 50.53% |
Stock Price Statistics
The stock price has decreased by -49.09% in the last 52 weeks. The beta is 1.23, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | -49.09% |
| 50-Day Moving Average | 41.79 |
| 200-Day Moving Average | 55.62 |
| Relative Strength Index (RSI) | 41.10 |
| Average Volume (20 Days) | 2,576,650 |
Short Selling Information
The latest short interest is 7.41 million, so 4.89% of the outstanding shares have been sold short.
| Short Interest | 7.41M |
| Short Previous Month | 6.48M |
| Short % of Shares Out | 4.89% |
| Short % of Float | 7.20% |
| Short Ratio (days to cover) | 2.55 |
Income Statement
In the last 12 months, Bruker had revenue of $3.45 billion and earned $79.60 million in profits. Earnings per share was $0.52.
| Revenue | 3.45B |
| Gross Profit | 1.72B |
| Operating Income | 400.30M |
| Pretax Income | 455.90M |
| Net Income | 79.60M |
| EBITDA | 599.80M |
| EBIT | 400.30M |
| Earnings Per Share (EPS) | $0.52 |
Balance Sheet
The company has $193.70 million in cash and $2.13 billion in debt, giving a net cash position of -$1.94 billion or -$12.80 per share.
| Cash & Cash Equivalents | 193.70M |
| Total Debt | 2.13B |
| Net Cash | -1.94B |
| Net Cash Per Share | -$12.80 |
| Equity (Book Value) | 1.85B |
| Book Value Per Share | 11.99 |
| Working Capital | 766.60M |
Cash Flow
In the last 12 months, operating cash flow was $294.50 million and capital expenditures -$119.90 million, giving a free cash flow of $174.60 million.
| Operating Cash Flow | 294.50M |
| Capital Expenditures | -119.90M |
| Free Cash Flow | 174.60M |
| FCF Per Share | $1.15 |
Margins
Gross margin is 49.90%, with operating and profit margins of 11.62% and 2.31%.
| Gross Margin | 49.90% |
| Operating Margin | 11.62% |
| Pretax Margin | 4.61% |
| Profit Margin | 2.31% |
| EBITDA Margin | 17.41% |
| EBIT Margin | 11.62% |
| FCF Margin | 5.07% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 38.10% |
| Buyback Yield | -2.88% |
| Shareholder Yield | -2.35% |
| Earnings Yield | 1.40% |
| FCF Yield | 3.07% |
Analyst Forecast
The average price target for Bruker is $58.50, which is 55.92% higher than the current price. The consensus rating is "Buy".
| Price Target | $58.50 |
| Price Target Difference | 55.92% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 5.72% |
| EPS Growth Forecast (5Y) | 42.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bruker has an Altman Z-Score of 2.91 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.91 |
| Piotroski F-Score | 4 |